0.8364

2.78% 0.0236

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $0.8364, with a volume of 417.22K. It is up +2.78% in the last 24 hours and down -7.18% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Previous Close:

$0.8128

Open:

$0.803

24h Volume:

417.22K

Relative Volume:

0.47

Market Cap:

$239.88M

Revenue:

$6.23M

Net Income/Loss:

$-95.90M

P/E Ratio:

5.576

EPS:

0.15

Net Cash Flow:

$-68.47M

1W Performance:

-0.85%

1M Performance:

-7.18%

6M Performance:

-41.17%

1Y Performance:

-30.96%

1-Day Range:

$0.803

$0.839

1-Week Range:

$0.7882

$0.8512

52-Week Range:

$0.7882

$1.93

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

202

Twitter

@precigen

Next Earnings Date

2024-11-07

Latest SEC Filings

PGEN's Discussions on Twitter

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

Nov 02, 2024

PGEN (Precigen) EBITDA per Share : $-0.52 (TTM As of Jun. 2024) - GuruFocus.com

Nov 02, 2024

Precigen Announces Pricing of $30.0 Million Public Offering of C - GuruFocus.com

Nov 02, 2024

Oct 31, 2024

Iridian Asset Management LLC CT Grows Stock Position in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat

Oct 31, 2024

Oct 30, 2024

PGEN stock touches 52-week low at $0.82 amid market challenges - Investing.com Australia

Oct 30, 2024

Oct 29, 2024

Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th - GuruFocus.com

Oct 29, 2024

Oct 24, 2024

High Growth Tech Stocks To Watch In October 2024 - Simply Wall St

Oct 24, 2024

Oct 18, 2024

Should you Hold Precigen (PGEN)? - Insider Monkey

Oct 18, 2024

Oct 12, 2024

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 12, 2024

Oct 11, 2024

A company insider recently bought 58,823 shares of Precigen Inc [PGEN]. Should You Buy? - Knox Daily

Oct 11, 2024

Precigen reclaims rights after terminating license agreement By Investing.com - Investing.com Australia

Oct 11, 2024